Regulated Water
Compare Stocks
2 / 10Stock Comparison
SBS vs DHR
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Diagnostics & Research
SBS vs DHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Regulated Water | Medical - Diagnostics & Research |
| Market Cap | $23.22B | $123.80B |
| Revenue (TTM) | $37.34B | $24.78B |
| Net Income (TTM) | $8.30B | $3.69B |
| Gross Margin | 36.6% | 60.7% |
| Operating Margin | 32.2% | 21.0% |
| Forward P/E | 3.4x | 20.7x |
| Total Debt | $39.99B | $18.42B |
| Cash & Equiv. | $4.67B | $4.62B |
SBS vs DHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Companhia de Saneam… (SBS) | 100 | 330.6 | +230.6% |
| Danaher Corporation (DHR) | 100 | 118.4 | +18.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SBS vs DHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SBS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.82, yield 2.1%
- Rev growth 3.3%, EPS growth -13.7%, 3Y rev CAGR 19.2%
- 379.1% 10Y total return vs DHR's 218.0%
In this particular matchup, DHR is outpaced on most metrics by others in the set.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.3% revenue growth vs DHR's 2.9% | |
| Value | Lower P/E (3.4x vs 20.7x), PEG 0.06 vs 34.20 | |
| Quality / Margins | 22.2% margin vs DHR's 14.9% | |
| Stability / Safety | Beta 0.82 vs DHR's 0.94 | |
| Dividends | 2.1% yield, 1-year raise streak, vs DHR's 0.7% | |
| Momentum (1Y) | +68.6% vs DHR's -7.2% | |
| Efficiency (ROA) | 8.8% ROA vs DHR's 4.5%, ROIC 13.1% vs 5.9% |
SBS vs DHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
SBS vs DHR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — SBS and DHR each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SBS is the larger business by revenue, generating $37.3B annually — 1.5x DHR's $24.8B. SBS is the more profitable business, keeping 22.2% of every revenue dollar as net income compared to DHR's 14.9%. On growth, DHR holds the edge at +3.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $37.3B | $24.8B |
| EBITDAEarnings before interest/tax | $14.2B | $7.2B |
| Net IncomeAfter-tax profit | $8.3B | $3.7B |
| Free Cash FlowCash after capex | -$726M | $5.3B |
| Gross MarginGross profit ÷ Revenue | +36.6% | +60.7% |
| Operating MarginEBIT ÷ Revenue | +32.2% | +21.0% |
| Net MarginNet income ÷ Revenue | +22.2% | +14.9% |
| FCF MarginFCF ÷ Revenue | -1.9% | +21.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -26.9% | +3.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +10.6% | +9.8% |
Valuation Metrics
SBS leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, SBS trades at a 61% valuation discount to DHR's 34.7x P/E. Adjusting for growth (PEG ratio), SBS offers better value at 0.25x vs DHR's 34.20x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $23.2B | $123.8B |
| Enterprise ValueMkt cap + debt − cash | $30.4B | $137.6B |
| Trailing P/EPrice ÷ TTM EPS | 13.53x | 34.71x |
| Forward P/EPrice ÷ next-FY EPS est. | 3.41x | 20.73x |
| PEG RatioP/E ÷ EPS growth rate | 0.25x | 34.20x |
| EV / EBITDAEnterprise value multiple | 10.56x | 18.14x |
| Price / SalesMarket cap ÷ Revenue | 3.07x | 5.04x |
| Price / BookPrice ÷ Book value/share | 2.64x | 2.37x |
| Price / FCFMarket cap ÷ FCF | — | 23.54x |
Profitability & Efficiency
DHR leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SBS delivers a 20.2% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $7 for DHR. DHR carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to SBS's 0.94x. On the Piotroski fundamental quality scale (0–9), DHR scores 7/9 vs SBS's 3/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +20.2% | +7.1% |
| ROA (TTM)Return on assets | +8.8% | +4.5% |
| ROICReturn on invested capital | +13.1% | +5.9% |
| ROCEReturn on capital employed | +15.2% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 |
| Debt / EquityFinancial leverage | 0.94x | 0.35x |
| Net DebtTotal debt minus cash | $35.3B | $13.8B |
| Cash & Equiv.Liquid assets | $4.7B | $4.6B |
| Total DebtShort + long-term debt | $40.0B | $18.4B |
| Interest CoverageEBIT ÷ Interest expense | 2.86x | 18.13x |
Total Returns (Dividends Reinvested)
SBS leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SBS five years ago would be worth $44,798 today (with dividends reinvested), compared to $7,907 for DHR. Over the past 12 months, SBS leads with a +68.6% total return vs DHR's -7.2%. The 3-year compound annual growth rate (CAGR) favors SBS at 55.5% vs DHR's -5.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +36.7% | -23.9% |
| 1-Year ReturnPast 12 months | +68.6% | -7.2% |
| 3-Year ReturnCumulative with dividends | +276.2% | -15.9% |
| 5-Year ReturnCumulative with dividends | +348.0% | -20.9% |
| 10-Year ReturnCumulative with dividends | +379.1% | +218.0% |
| CAGR (3Y)Annualised 3-year return | +55.5% | -5.6% |
Risk & Volatility
SBS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SBS is the less volatile stock with a 0.82 beta — it tends to amplify market swings less than DHR's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBS currently trades 92.7% from its 52-week high vs DHR's 72.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.82x | 0.94x |
| 52-Week HighHighest price in past year | $35.78 | $242.80 |
| 52-Week LowLowest price in past year | $18.88 | $172.06 |
| % of 52W HighCurrent price vs 52-week peak | +92.7% | +72.0% |
| RSI (14)Momentum oscillator 0–100 | 55.4 | 32.3 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 4.1M |
Analyst Outlook
SBS leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates SBS as "Hold" and DHR as "Buy". Consensus price targets imply 41.2% upside for DHR (target: $247) vs -28.3% for SBS (target: $24). For income investors, SBS offers the higher dividend yield at 2.07% vs DHR's 0.71%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $23.79 | $247.00 |
| # AnalystsCovering analysts | 7 | 42 |
| Dividend YieldAnnual dividend ÷ price | +2.1% | +0.7% |
| Dividend StreakConsecutive years of raises | 1 | 1 |
| Dividend / ShareAnnual DPS | $3.39 | $1.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +2.5% |
SBS leads in 4 of 6 categories (Valuation Metrics, Total Returns). DHR leads in 1 (Profitability & Efficiency). 1 tied.
SBS vs DHR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is SBS or DHR a better buy right now?
For growth investors, Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) is the stronger pick with 3.
3% revenue growth year-over-year, versus 2. 9% for Danaher Corporation (DHR). Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) offers the better valuation at 13. 5x trailing P/E (3. 4x forward), making it the more compelling value choice. Analysts rate Danaher Corporation (DHR) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SBS or DHR?
On trailing P/E, Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) is the cheapest at 13.
5x versus Danaher Corporation at 34. 7x. On forward P/E, Companhia de Saneamento Básico do Estado de São Paulo - SABESP is actually cheaper at 3. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Companhia de Saneamento Básico do Estado de São Paulo - SABESP wins at 0. 06x versus Danaher Corporation's 34. 20x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SBS or DHR?
Over the past 5 years, Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) delivered a total return of +348.
0%, compared to -20. 9% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: SBS returned +379. 1% versus DHR's +218. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SBS or DHR?
By beta (market sensitivity over 5 years), Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) is the lower-risk stock at 0.
82β versus Danaher Corporation's 0. 94β — meaning DHR is approximately 14% more volatile than SBS relative to the S&P 500. On balance sheet safety, Danaher Corporation (DHR) carries a lower debt/equity ratio of 35% versus 94% for Companhia de Saneamento Básico do Estado de São Paulo - SABESP — giving it more financial flexibility in a downturn.
05Which is growing faster — SBS or DHR?
By revenue growth (latest reported year), Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) is pulling ahead at 3.
3% versus 2. 9% for Danaher Corporation (DHR). On earnings-per-share growth, the picture is similar: Danaher Corporation grew EPS -4. 7% year-over-year, compared to -13. 7% for Companhia de Saneamento Básico do Estado de São Paulo - SABESP. Over a 3-year CAGR, SBS leads at 19. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SBS or DHR?
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) is the more profitable company, earning 22.
2% net margin versus 14. 7% for Danaher Corporation — meaning it keeps 22. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SBS leads at 32. 2% versus 20. 9% for DHR. At the gross margin level — before operating expenses — DHR leads at 60. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SBS or DHR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) is the more undervalued stock at a PEG of 0. 06x versus Danaher Corporation's 34. 20x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) trades at 3. 4x forward P/E versus 20. 7x for Danaher Corporation — 17. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 41. 2% to $247. 00.
08Which pays a better dividend — SBS or DHR?
All stocks in this comparison pay dividends.
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) offers the highest yield at 2. 1%, versus 0. 7% for Danaher Corporation (DHR).
09Is SBS or DHR better for a retirement portfolio?
For long-horizon retirement investors, Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
82), 2. 1% yield, +379. 1% 10Y return). Both have compounded well over 10 years (SBS: +379. 1%, DHR: +218. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SBS and DHR?
These companies operate in different sectors (SBS (Utilities) and DHR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SBS is a mid-cap deep-value stock; DHR is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.